Stock Events

Stock Events

C4 Therapeutics (CCCC) Q2 2023 Earnings

8AugConfirmed

Nov 22

Q4 2022

Q1 2023

Q2 2023

-0.76

-0.72

-0.69

-0.65

Details

Expected EPS

-0.69

Actual EPS

-0.73

Surprise EPS

-0.04

Surprise Percent

+5.8%

Description

C4 Therapeutics (CCCC) has reported earnings of -0.73 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.